SPATS2L

SPATS2-like protein · Q9NUQ6 · SPATS2L on Sugi Atlas →

0 patent compounds predicted against SPATS2L, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SPATS2L by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia PHASE2/PHASE3COMPLETED
Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men PHASE3ACTIVE_NOT_RECRUITING
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Cognitive Disorders in Hereditary Spastic Paraplegia Type 4 nanUNKNOWN
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias nanCOMPLETED
Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias nanUNKNOWN
Consequences of Mutations in the SPG7 Gene at the Heterozygous State nanCOMPLETED
Spastic Paraplegia - Centers of Excellence Research Network nanRECRUITING
Evaluation of an Intensive Training Program for Patients with Hereditary Spastic Paraparesis SPG4/Spast nanRECRUITING
Efficacy of Pain Neuroscience Education and Physiotherapy in Patients Diagnosed with Spondyloarthritis nanCOMPLETED
Natural History and Development of Spondyloarthritis nanRECRUITING
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq) nanRECRUITING
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
New Genes in the Carcinogenesis of Colorectal Cancer nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Ohio Colorectal Cancer Prevention Initiative nanCOMPLETED
Studying Cognition in SPG4 nanCOMPLETED
Imaging Biomarkers in Crohn's Associated Spondyloarthritis nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
CIQTP Prolongation : Role and Mechanism in Sudden Cardiac Death nanCOMPLETED
Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease nanCOMPLETED
Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Surfactant Derived Protocol in Heart Failure nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SPATS2L binder may also engage these)

ProteinNameSimilarity
Q5U2T3 1.000 Q5U2T3 →
Q91WJ7 1.000 Q91WJ7 →
Q86XZ4 0.994 Q86XZ4 →
Q8K1N4 0.987 Q8K1N4 →
Q9UBW5 0.986 Q9UBW5 →
Q07E15 0.985 Q07E15 →
Q92833 0.984 Q92833 →
Q09YI1 0.984 Q09YI1 →
D3ZUI5 0.982 D3ZUI5 →
Q5RHD1 0.982 Q5RHD1 →
Q2IBB2 0.982 Q2IBB2 →
Q4V7W5 0.981 Q4V7W5 →
B2GUN4 0.981 B2GUN4 →
Q2QLA2 0.980 Q2QLA2 →
O54828 0.980 O54828 →
Q4KKX4 0.980 Q4KKX4 →
Q96T21 0.980 Q96T21 →
Q32S26 0.980 Q32S26 →
Q99LJ0 0.979 Q99LJ0 →
Q62925 0.979 Q62925 →
Q9JKB5 0.979 Q9JKB5 →
Q09YG9 0.979 Q09YG9 →
O35589 0.979 O35589 →
Q62415 0.979 Q62415 →
Q8K3I4 0.979 Q8K3I4 →
A5PLL1 0.978 A5PLL1 →
Q5RIX9 0.978 Q5RIX9 →
Q6Y685 0.978 Q6Y685 →
Q9Y4F3 0.978 Q9Y4F3 →
Q8CG79 0.978 Q8CG79 →